The federal development board for Southern Ontario has injected $5m to accelerate the growth potential of TIAP's early-stage health sciences portfolio.
Five years after being co-founded by UCL researchers, Ori Biotech has brought its overall funding to $41m.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Oxford Nanopore has continued its funding streak with another $108m, bringing this year's haul to more than $208m and its overall total to around $800m.
MIT's cancer drug developer Kronos Bio floated above its range in an upsized offering and saw its shares soar in price post-IPO.
Galecto has filed to go public nine years after being founded in Sweden to commercialise research from Lund and Edinburgh universities.